Tyra Biosciences, Inc. (TYRA)
NASDAQ: TYRA · Real-Time Price · USD
36.32
-0.21 (-0.56%)
At close: Mar 24, 2026, 4:00 PM EDT
36.32
0.00 (0.00%)
After-hours: Mar 24, 2026, 4:03 PM EDT
Tyra Biosciences Employees
Tyra Biosciences had 87 employees as of December 31, 2025. The number of employees increased by 27 or 45.00% compared to the previous year.
Employees
87
Change (1Y)
27
Growth (1Y)
45.00%
Revenue / Employee
n/a
Profits / Employee
-$1,378,701
Market Cap
1.97B
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Dec 31, 2025 | 87 | 27 | 45.00% |
| Dec 31, 2024 | 60 | 11 | 22.45% |
| Dec 31, 2023 | 49 | 11 | 28.95% |
| Dec 31, 2022 | 38 | 13 | 52.00% |
| Dec 31, 2021 | 25 | 12 | 92.31% |
| Jun 30, 2021 | 16 | - | - |
| Mar 31, 2021 | 13 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| Zai Lab | 1,784 |
| Ultragenyx Pharmaceutical | 1,371 |
| Ascentage Pharma Group International | 605 |
| Galapagos NV | 558 |
| Stoke Therapeutics | 170 |
| Aurinia Pharmaceuticals | 128 |
| Definium Therapeutics | 106 |
| Mesoblast | 81 |
TYRA News
- 21 days ago - Tyra Biosciences Reports Fourth Quarter and Full-Year 2025 Financial Results and Recent Highlights - PRNewsWire
- 4 weeks ago - Tyra Biosciences Announces Poster Presentations at the 2026 ASCO® Genitourinary (GU) Cancers Symposium - PRNewsWire
- 4 weeks ago - Tyra Biosciences to Participate in Upcoming Investor Conferences - PRNewsWire
- 4 months ago - Tyra Biosciences Strengthens Leadership Team with Appointments of Bhavesh Ashar as Chief Operating Officer and Heather Faulds as Chief Regulatory Officer - PRNewsWire
- 4 months ago - Tyra Biosciences Announces Participation at Upcoming Investor Events - PRNewsWire
- 4 months ago - Tyra Biosciences Reports Third Quarter 2025 Financial Results and Highlights - PRNewsWire
- 7 months ago - Tyra Biosciences Announces First Child Dosed in BEACH301, its Phase 2 Study for Dabogratinib (TYRA-300) in Pediatric Achondroplasia - PRNewsWire
- 7 months ago - Tyra Biosciences Reports Second Quarter 2025 Financial Results and Highlights - PRNewsWire